250 related articles for article (PubMed ID: 17925486)
1. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.
Fujii H; Cuvelier G; She K; Aslanian S; Shimizu H; Kariminia A; Krailo M; Chen Z; McMaster R; Bergman A; Goldman F; Grupp SA; Wall DA; Gilman AL; Schultz KR
Blood; 2008 Mar; 111(6):3276-85. PubMed ID: 17925486
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.
Cuvelier GD; Kariminia A; Fujii H; Aslanian S; Wall D; Goldman F; Grupp SA; Dunn SE; Krailo M; Shapiro LH; Gilman A; Schultz KR
Bone Marrow Transplant; 2010 Nov; 45(11):1653-7. PubMed ID: 20190833
[TBL] [Abstract][Full Text] [Related]
3. Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.
Rozmus J; Schultz KR; Wynne K; Kariminia A; Satyanarayana P; Krailo M; Grupp SA; Gilman AL; Goldman FD
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1804-13. PubMed ID: 21669298
[TBL] [Abstract][Full Text] [Related]
4. Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.
She K; Gilman AL; Aslanian S; Shimizu H; Krailo M; Chen Z; Reid GS; Wall D; Goldman F; Schultz KR
Biol Blood Marrow Transplant; 2007 Apr; 13(4):386-97. PubMed ID: 17382246
[TBL] [Abstract][Full Text] [Related]
5. A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study.
Cuvelier GDE; Ng B; Abdossamadi S; Nemecek ER; Melton A; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; Ostroumov E; Schultz KR
Blood Adv; 2023 Jul; 7(14):3612-3623. PubMed ID: 36219586
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Kariminia A; Holtan SG; Ivison S; Rozmus J; Hebert MJ; Martin PJ; Lee SJ; Wolff D; Subrt P; Abdossamadi S; Sung S; Storek J; Levings M; Aljurf M; Arora M; Cutler C; Gallagher G; Kuruvilla J; Lipton J; Nevill TJ; Newell LF; Panzarella T; Pidala J; Popradi G; Szwajcer D; Tay J; Toze CL; Walker I; Couban S; Storer BE; Schultz KR
Blood; 2016 Jun; 127(24):3082-91. PubMed ID: 27020088
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease.
Subburaj D; Ng B; Kariminia A; Abdossamadi S; Lauener M; Nemecek ER; Rozmus J; Kharbanda S; Kitko CL; Lewis VA; Schechter-Finklestein T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Coulter D; Chewning JH; Joyce M; Pawlowska AB; Megason GC; Lawitschka A; Ostroumov E; Klein Geltink R; Cuvelier GDE; Schultz KR
Blood; 2022 Jan; 139(2):287-299. PubMed ID: 34534280
[TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free mitochondrial DNA as a diagnostic and prognostic biomarker in chronic and late acute graft-versus-host disease in children.
Azadpour S; Abdossamadi S; Ng B; Ostroumov E; Abroun S; Cuvelier GDE; Schultz KR
Exp Hematol; 2023 May; 121():12-17. PubMed ID: 36868452
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.
Rozmus J; Kariminia A; Abdossamadi S; Storer BE; Martin PJ; Lee SJ; Wolff D; Arora M; Cutler C; Schultz KR
Biol Blood Marrow Transplant; 2019 Mar; 25(3):451-458. PubMed ID: 30447393
[TBL] [Abstract][Full Text] [Related]
10. Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation.
Hao B; Gao S; Sang YW; Wang L; Meng XQ; You JY
J Zhejiang Univ Sci B; 2019 Oct.; 20(10):849-860. PubMed ID: 31489804
[TBL] [Abstract][Full Text] [Related]
11. Chronic graft-versus-host disease in children and adolescents after bone marrow transplantation from HLA-matched donors.
Yumura-Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Nakano T; Nomura K; Nakano T; Park DY; Endo C; Nishiuchi R; Sawada A; Matsuda Y; Oota H; Yoshimoto T; Kawa-Ha K
Int J Hematol; 2000 Apr; 71(3):278-82. PubMed ID: 10846836
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ
Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease.
Soderberg C; Larsson S; Rozell BL; Sumitran-Karuppan S; Ljungman P; Moller E
Transplantation; 1996 Feb; 61(4):600-9. PubMed ID: 8610388
[TBL] [Abstract][Full Text] [Related]
14. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
Front Immunol; 2019; 10():1879. PubMed ID: 31507582
[TBL] [Abstract][Full Text] [Related]
15. CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease.
Giesen N; Schwarzbich MA; Dischinger K; Becker N; Hummel M; Benner A; Radujkovic A; Müller-Tidow C; Dreger P; Luft T
Transplantation; 2020 Nov; 104(11):2354-2359. PubMed ID: 31929430
[TBL] [Abstract][Full Text] [Related]
16. High levels of anti-cytoskeleton autoantibodies are frequently associated with chronic GVHD.
Dighiero G; Intrator L; Cordonnier C; Tortevoye P; Vernant JP
Br J Haematol; 1987 Nov; 67(3):301-5. PubMed ID: 3318912
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.
Gilman AL; Schultz KR; Goldman FD; Sale GE; Krailo MD; Chen Z; Langholz B; Jacobsohn DA; Chan KW; Ryan RE; Kellick M; Neudorf SM; Godder K; Sandler ES; Sahdev I; Grupp SA; Sanders JE; Wall DA
Biol Blood Marrow Transplant; 2012 Jan; 18(1):84-91. PubMed ID: 21689773
[TBL] [Abstract][Full Text] [Related]
18. Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.
Du J; Flynn R; Paz K; Ren HG; Ogata Y; Zhang Q; Gafken PR; Storer BE; Roy NH; Burkhardt JK; Mathews W; Tolar J; Lee SJ; Blazar BR; Paczesny S
Blood; 2018 Apr; 131(15):1743-1754. PubMed ID: 29348127
[TBL] [Abstract][Full Text] [Related]
19. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
[TBL] [Abstract][Full Text] [Related]
20. Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD.
Rozmus J; Ivison S; Kariminia A; Leung VM; Sung S; Subrt P; Lee SJ; Boilard E; Walker I; Foley R; Lipton J; Gallagher G; Couban S; Schultz KR
Bone Marrow Transplant; 2018 Oct; 53(10):1263-1269. PubMed ID: 29563589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
